Nijmegen Breakage Syndrome — Clinical Trials

MONDO:00096232 active·1 recruitingLast updated: Mar 18, 2026, 8:53 PM

Nijmegen Breakage Syndrome has an emerging clinical trial program, driven by drug treatment.

Recruiting

Active Trials

Drug Treatment2

Phase 2

Academic/Other2

Russia1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 2Recruiting

Sponsor:Federal Research Institute of Pediatric Hematology, Oncology and Immunology

RussiaStarted: Nov 2023Est. completion: Jan 2029Updated: Jan 2024

Last updated over 18 months ago

Phase 2Not Yet Recruiting

Sponsor:Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Started: Dec 2025Est. completion: Dec 2030Updated: Jan 2026

Stay informed about clinical trials for Nijmegen Breakage Syndrome.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 18, 2026 at 8:53 PM